Synergistic Antibacterial Effect of ZnO Nanoparticles and Antibiotics against Multidrug-resistant Biofilm Bacteria
Authors:
- 1 January 2025
- journal article
- research article
- Published by Bentham Science Publishers Ltd. in Current Drug Delivery
- Vol. 22 (1) , 92-106
Abstract
Background: The misuse of antibiotics leads to a global increase in antibiotic resistance. Therefore, it is imperative to search for alternative compounds to conventional antibiotics. ZnO nanoparticles (Zn NP) are one of these alternatives because they are an effective option to overcome biofilm bacterial cells and a novel way to overcome multidrug resistance in bacteria. The current research study aims to characterize the efficacy of ZnO nanoparticles alone and in combination with other antibacterial drugs against bacterial biofilms. Methods: ZnO NPs were prepared by co-precipitation method, and their anti-biofilm and antibacterial activities alone or combined with four types of broad-spectrum antibacterial (Norfloxacin, Colistin, Doxycycline, and Ampicillin) were evaluated against E. coli and S. aureus bacterial strains. Finally, the cytotoxicity and the hemolytic activity were evaluated. Results: ZnO NPs were prepared, and results showed that their size was around 10 nm with a spherical shape and a zeta potential of -21.9. In addition, ZnO NPs were found to have a strong antibacterial effect against Gram-positive and Gram-negative microorganisms, with a minimum inhibitory concentration (MIC) of 62.5 and 125 μg/mL, respectively. Additionally, they could eradicate biofilmforming microorganisms at a concentration of 125 μg/m. ZnO NPs were found to be non-toxic to erythrocyte cells. Still, some toxicity was observed for Vero cells at effective concentration ranges needed to inhibit bacterial growth and eradicate biofilm-forming organisms. When combined with different antibacterial, ZnO NP demonstrated synergistic and additive effects with colistin, and the MIC and MBEC of the combination decreased significantly to 0.976 μg/mL against planktonic and biofilm strains of MDR Gram-positive bacteria, resulting in significantly reduced toxicity. Conclusion: The findings of this study encourage the development of alternative therapies with high efficacy and low toxicity. ZnO nanoparticles have demonstrated promising results in overcoming multi-drug resistant bacteria and biofilms, and their combination with colistin has shown a significant reduction in toxicity. Further studies are needed to investigate the potential of ZnO nanoparticles as a viable alternative to conventional antibiotics.Keywords
Funding Information
- Deanship of Research at Jordan University of Science and Technology (JUST), Irbid, Jordan (518/2020)
This publication has 78 references indexed in Scilit:
- Spatiotemporal Catalytic Nanozymes Microneedle Patches with Opposite Properties for Wound ManagementSmall, 2023
- In Situ Sprayed Difunctional Gel Avoiding Microenvironments Limitations to Treat Pressure UlcersMacromolecular Bioscience, 2023
- Titanium dioxide nanoparticles: Recent progress in antimicrobial applicationsWIREs Nanomedicine and Nanobiotechnology, 2022
- Zinc oxide nanoparticle inhibits the biofilm formation of Streptococcus pneumoniaeAntonie van Leeuwenhoek, 2017
- Gramicidin A Mutants with Antibiotic Activity against Both Gram‐Positive and Gram‐Negative BacteriaChemMedChem, 2016
- Effect of calcination temperature on the properties of ZnO nanoparticlesApplied Physics A, 2015
- Enhanced Efficacy of Superparamagnetic Iron Oxide Nanoparticles Against Antibiotic‐Resistant Biofilms in the Presence of MetabolitesAdvanced Materials, 2013
- Esculentin(1-21), an amphibian skin membrane-active peptide with potent activity on both planktonic and biofilm cells of the bacterial pathogen Pseudomonas aeruginosaCellular and Molecular Life Sciences, 2013
- ZnO nanoparticles enhanced antibacterial activity of ciprofloxacin against Staphylococcus aureus and Escherichia coliJournal of Biomedical Materials Research Part B: Applied Biomaterials, 2010
- Photoluminesence and FTIR study of ZnO nanoparticles: the impurity and defect perspectivephysica status solidi (c), 2006